The University of Tokyo is a public research university in Bunkyō, Tokyo, Japan. Founded in 1877 as the nation's first modern university by the merger of several pre-westernisation era institutions, its direct precursors include the Tenmongata, founded in 1684, and the Shoheizaka Institute.
Cancer Cell is a peer-reviewed scientific journal scientific journal that publishes articles that provide major advances in cancer research and oncology. The journal considers manuscripts that answer important questions relevant to naturally occurring cancers. Areas covered include basic cancer biology, therapeutic development, translational research, cancer model development, multi-omics and computational biology. Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.
Japanese studies or Japan studies, sometimes known as Japanology in Europe, is a sub-field of area studies or East Asian studies involved in social sciences and humanities research on Japan. It incorporates fields such as the study of Japanese language, history, culture, literature, philosophy, art, music, cinema, and science.
Uyoku dantai refers to Japanese ultranationalist far-right activists, provocateurs, and internet trolls often organized in groups. In 1996 and 2013, the National Police Agency estimated that there were over 1,000 right-wing groups in Japan with about 100,000 members in total.
The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 58,000 members in 142 countries and territories. The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
The European Institute of Oncology is a non-profit private-law comprehensive cancer centre located in Milan, Italy. It serves as a clinic, a research centre, and a training institution. IEO is a member of EU-LIFE, an alliance of leading life science research centres in Europe.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 45.3 as reported by Clarivate in its 2022 Journal Citation Reports.
Clinical Lung Cancer is a peer-reviewed medical journal that has been published by Elsevier since 2011. It was established by the CIG Media Group in 1999.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
The Japanese Foundation for Cancer Research (公益財団法人がん研究会) (JFCR) is a non-profit cancer research organization based in Ariake, Tokyo. The JFCR was founded in 1908 as the first Japanese organization specializing in cancer by Katsusaburō Yamagiwa and his supporters. The Cancer Institute and its attached hospital of JFCR were set up in 1934. The JFCR became a full member of the Union for International Cancer Control in 1968.
The Japanese Cancer Association (JCA) is the oldest professional association related to cancer research in Japan. Based in Shinjuku, Tokyo, it focuses on all aspects of cancer research, including basic, clinical and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1941, the JCA has more than 16,000 members.
Takashi Sugimura was a Japanese biochemist, famous for research on chemical carcinogens. He received the Japan Prize for the contribution to establishment of fundamental concept on causes of cancer. He was elected as President of the Japan Academy on October 15, 2013, serving till 2016 and was replaced with Hiroshi Shiono.
The Journal of Neuro-Oncology is a peer-reviewed medical journal covering cancer of the central nervous system. It was established in 1983 and is published 15 times per year by Springer Science+Business Media. It was originally published by Martinus Nijhoff Publishers and has been published by Springer since 2005. It is the oldest continuously published journal focused on the field of Neuro-Oncology.
Demetrios A. Spandidos is a Greek virologist and cancer researcher. He is an emeritus professor at the University of Crete where he was professor of virology from 1989 till 2015. He is also the founder of Spandidos Publications and the editor-in-chief of all eight of its journals.
The Philosophical Association of Japan is the largest learned society for philosophy in Japan. The purpose of the association is to "promote the study of philosophy and active interaction among researchers from philosophy, working as a forum to discuss on research, education and the role of philosophy in the modern world." The association was founded by Japanese philosophers in 1949, with Amano Teiyū being elected its first president. Since 1952, the association has published the journal Philosophy annually, with Volume 69 releasing in April 2018.
Ashok K. Vaid is an Indian medical oncologist, who specializes in bone marrow transplantation. He is credited with the performance of the first 25 bone marrow transplantations in the private sector in North India. He heads the Cancer Institute- Division of Medical Oncology and Haemotology at Medanta The Medicity.
Darab Jehangir Jussawala (1915–1999) was an Indian medical-cum-surgical oncologist, medical writer and the director of Tata Memorial Centre. He was the co-founder of Indian Cancer Society, along with Naval Tata in 1951, and the founder of the Indian Cancer Rehabilitation Centre in Parel, Mumbai, in 1956, the first such centre in India and the largest in Asia. He served as the director of Lady Ratan Tata Medical and Research Center and as the honorary consultant at two Mumbai hospitals, Breach Candy Hospital and Jaslok Hospital. An elected fellow of the Royal Society of Medicine, National Academy of Medical Sciences, Indian Academy of Sciences, Indian National Science Academy and the American College of Surgeons, he was a recipient of the Dhanwantari Award as well as several Oration Awards. The Government of India awarded him the third highest civilian honour of the Padma Bhushan, in 1975, for his contributions to Medicine.
The Japan Medical Association, is the largest professional association of licensed physicians in Japan. The JMA has been a member of the World Medical Association since 1951 and participates at all levels of the WMA. National headquarters are located in Honkomagome, Bunkyō, Tokyo, Japan, supplemented by prefectural branch offices and member associations in local communities.
Tumor Biology is a bimonthly peer-reviewed open access medical journal covering clinical and experimental oncology. It was established in 1980 as Oncodevelopmental Biology and Medicine, obtaining its current name in 1984. It is owned by the International Society of Oncology and BioMarkers, of which it is the official journal. Originally published by Karger Publishers, it moved to Springer Science+Business Media beginning in 2010. In December 2016, the journal moved again, this time to SAGE Publications. The editor-in-chief is Magdalena Chechlinska. According to the Journal Citation Reports, the journal has a 2016 impact factor of 3.650.
The Japanese Association of Medical Sciences is a suborganization of the Japan Medical Association (日本医師会) devoted to the development and promotion of science and research in medicine. The Japanese Association of Medical Sciences was founded independently of the Japan Medical Association in 1902 as a collaboration between 16 medical societies in Japan. Since their founding, they have held a general assembly called the Japan Medical Congress every four years except in 1947 when it was postponed for a year due to the Second World War. In 1948, they held their twelfth assembly at which point they merged with the Japan Medical Association, which has remained their parent organization since. Rather than individuals, the Japanese Association of Medical Sciences has member societies. As of 2019, they have 132 member societies.
